Metastatic Cancer

Oncology·MeSH: Carcinoma, Adenoid Cystic

8 drugs in development·8 companies·34 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
tak-280	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-280	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 2(1)

Drug	Company
incb001158	Incyte Corp. (INCY)

Phase 1(2)

Drug	Company
AU-007	ENANTA PHARMACEUTICALS INC (ENTA)
Entinostat	Syndax Pharmaceuticals Inc (SNDX)

Preclinical(3)

Drug	Company
mena-targeted therapeutic candidates	METASTAT, INC. (MTST)
pop1 program	Propanc Biopharma, Inc. (PPCB)
SPX-1009	AXIM BIOTECHNOLOGIES, INC. (AXIM)

BioSniper tracks 8 drugs in development for Metastatic Cancer across 8 companies.

There are 34 clinical trials targeting Metastatic Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.